Vaginitis News and Research

RSS
Vaginitis is described medically as irritation and/or inflammation of the vagina. Vaginitis is a very common disease affecting millions of women each year. The three most common vaginal infections are bacterial vaginosis (BV), candida vaginitis (yeast infection) and trichomonas vaginitis ("trich").

Vaginal infections can produce a variety of symptoms, such as abnormal or increased discharge, itching, fishy odor, irritation, painful urination or vaginal bleeding. When you have vaginitis, you may have some or all of these symptoms.
SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

SGLT-2 inhibitors do not increase the risk of UTIs in diabetics, concludes study

Researcher explores genitourinary health of sexually abused children

Researcher explores genitourinary health of sexually abused children

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

WPI-led study provides clues to new ways to treat difficult-to-cure fungal infections

WPI-led study provides clues to new ways to treat difficult-to-cure fungal infections

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Penn, UGA scientists awarded new contract to develop genome database for microbial pathogens

Penn, UGA scientists awarded new contract to develop genome database for microbial pathogens

Chemical compound prevents fungal cells from adhering to surfaces

Chemical compound prevents fungal cells from adhering to surfaces

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

BioDiem granted European patent for antimicrobial drug

BioDiem granted European patent for antimicrobial drug

New diagnostic test for Trichomonas vaginalis

New diagnostic test for Trichomonas vaginalis

Watson commences Esmya Phase 3 trial in women with anemia linked to uterine leiomyomas

Watson commences Esmya Phase 3 trial in women with anemia linked to uterine leiomyomas

Merck's NEXPLANON 68 mg now available in the U.S.

Merck's NEXPLANON 68 mg now available in the U.S.

FDA approves two new strengths of Lupron Depot-PED for central precocious puberty

FDA approves two new strengths of Lupron Depot-PED for central precocious puberty

Gen-Probe receives FDA marketing clearance for APTIMA Trichomonas vaginalis assay

Gen-Probe receives FDA marketing clearance for APTIMA Trichomonas vaginalis assay

Study finds AFFIRM assay may accurately detect Trichamonos vaginalis

Study finds AFFIRM assay may accurately detect Trichamonos vaginalis

New study: Asthma may have relationship with airway microbiota composition

New study: Asthma may have relationship with airway microbiota composition

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Scientists to identify microbial risk predictors for preterm birth

Scientists to identify microbial risk predictors for preterm birth

Novo Nordisk reaches exclusive agreement to market Vagifem 10 mcg

Novo Nordisk reaches exclusive agreement to market Vagifem 10 mcg